Primary PTCA: Possibly the Best, Often the Only Choice for Reperfusion in Acute Myocardial Infarction View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1997-09

AUTHORS

Gabriel Steg, Patrick Seknadji

ABSTRACT

Primary PTCA is at least as effective as intravenous thrombolysis for the management of acute myocardial infarction. When the capability for primary PTCA exists, it is also a very cost-effective treatment, allowing earlier hospital discharge, reduced readmissions and reduced risks of recurrent ischemia and infarction. Finally, many patients with acute myocardial infarction either have contraindications to thrombolysis or fail to fulfill the clinical and ECG criteria for thrombolysis. In these patients, the only possible reperfusion therapy is primary PTCA: it is potentially applicable to all patients with ongoing acute myocardial infarction, without contraindications, which may lead to a substantial increase in the proportion of acute myocardial infarction patients receiving reperfusion therapy. Its use is limited by logistical problems: permanent availability of interventional cardiology facilities and staff, need for secondary transfer of patients from primary care centers. Currently, it appears reasonable to use pre-hospital medical systems as often as possible to triage patients excluded from thrombolysis as well as the most severe thrombolysis-eligible to centers able to perform primary PTCA round the clock, which exist in nearly every large urban center. When the patient is thrombolysis-eligible and is within a center in which interventional facilities and experienced teams are immediately available, both treatments are legitimate, although primary PTCA may be favored both in terms of outcome and cost. Conversely, when the patient has no contraindication to thrombolysis and cannot be treated rapidly in a center with interventional capabilities, thrombolytic therapy should remain the preferred treatment. More... »

PAGES

331-336

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1008837014116

DOI

http://dx.doi.org/10.1023/a:1008837014116

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026647935

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10639637


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiology Department, H\u00f6pital Bichat, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Cardiology Department, H\u00f6pital Bichat, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steg", 
        "givenName": "Gabriel", 
        "id": "sg:person.01300751563.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300751563.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiology Department, H\u00f6pital Bichat, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Cardiology Department, H\u00f6pital Bichat, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seknadji", 
        "givenName": "Patrick", 
        "id": "sg:person.01221261443.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221261443.91"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1997-09", 
    "datePublishedReg": "1997-09-01", 
    "description": "Primary PTCA is at least as effective as intravenous thrombolysis for the management of acute myocardial infarction. When the capability for primary PTCA exists, it is also a very cost-effective treatment, allowing earlier hospital discharge, reduced readmissions and reduced risks of recurrent ischemia and infarction. Finally, many patients with acute myocardial infarction either have contraindications to thrombolysis or fail to fulfill the clinical and ECG criteria for thrombolysis. In these patients, the only possible reperfusion therapy is primary PTCA: it is potentially applicable to all patients with ongoing acute myocardial infarction, without contraindications, which may lead to a substantial increase in the proportion of acute myocardial infarction patients receiving reperfusion therapy. Its use is limited by logistical problems: permanent availability of interventional cardiology facilities and staff, need for secondary transfer of patients from primary care centers. Currently, it appears reasonable to use pre-hospital medical systems as often as possible to triage patients excluded from thrombolysis as well as the most severe thrombolysis-eligible to centers able to perform primary PTCA round the clock, which exist in nearly every large urban center. When the patient is thrombolysis-eligible and is within a center in which interventional facilities and experienced teams are immediately available, both treatments are legitimate, although primary PTCA may be favored both in terms of outcome and cost. Conversely, when the patient has no contraindication to thrombolysis and cannot be treated rapidly in a center with interventional capabilities, thrombolytic therapy should remain the preferred treatment.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1008837014116", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3-4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "acute myocardial infarction", 
      "primary PTCA", 
      "myocardial infarction", 
      "reperfusion therapy", 
      "ongoing acute myocardial infarction", 
      "acute myocardial infarction patients", 
      "interventional cardiology facilities", 
      "early hospital discharge", 
      "primary care centers", 
      "myocardial infarction patients", 
      "cost-effective treatment", 
      "intravenous thrombolysis", 
      "recurrent ischemia", 
      "hospital discharge", 
      "reduced readmissions", 
      "terms of outcomes", 
      "thrombolytic therapy", 
      "infarction patients", 
      "preferred treatment", 
      "care center", 
      "interventional facilities", 
      "thrombolysis", 
      "reduced risk", 
      "infarction", 
      "patients", 
      "ECG criteria", 
      "PTCA", 
      "experienced team", 
      "contraindications", 
      "interventional capabilities", 
      "therapy", 
      "treatment", 
      "medical system", 
      "secondary transfer", 
      "readmission", 
      "reperfusion", 
      "ischemia", 
      "large urban centers", 
      "center", 
      "logistical problems", 
      "outcomes", 
      "substantial increase", 
      "risk", 
      "only choice", 
      "staff", 
      "proportion", 
      "management", 
      "discharge", 
      "criteria", 
      "team", 
      "increase", 
      "facilities", 
      "use", 
      "need", 
      "urban centers", 
      "permanent availability", 
      "choice", 
      "availability", 
      "cost", 
      "system", 
      "terms", 
      "transfer", 
      "clock", 
      "problem", 
      "capability", 
      "only possible reperfusion therapy", 
      "possible reperfusion therapy", 
      "cardiology facilities", 
      "pre-hospital medical systems"
    ], 
    "name": "Primary PTCA: Possibly the Best, Often the Only Choice for Reperfusion in Acute Myocardial Infarction", 
    "pagination": "331-336", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026647935"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1008837014116"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10639637"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1008837014116", 
      "https://app.dimensions.ai/details/publication/pub.1026647935"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_293.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1008837014116"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1008837014116'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1008837014116'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1008837014116'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1008837014116'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      21 PREDICATES      96 URIs      88 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1008837014116 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nf1b36b86837f401199ab31fb7ea60210
4 schema:datePublished 1997-09
5 schema:datePublishedReg 1997-09-01
6 schema:description Primary PTCA is at least as effective as intravenous thrombolysis for the management of acute myocardial infarction. When the capability for primary PTCA exists, it is also a very cost-effective treatment, allowing earlier hospital discharge, reduced readmissions and reduced risks of recurrent ischemia and infarction. Finally, many patients with acute myocardial infarction either have contraindications to thrombolysis or fail to fulfill the clinical and ECG criteria for thrombolysis. In these patients, the only possible reperfusion therapy is primary PTCA: it is potentially applicable to all patients with ongoing acute myocardial infarction, without contraindications, which may lead to a substantial increase in the proportion of acute myocardial infarction patients receiving reperfusion therapy. Its use is limited by logistical problems: permanent availability of interventional cardiology facilities and staff, need for secondary transfer of patients from primary care centers. Currently, it appears reasonable to use pre-hospital medical systems as often as possible to triage patients excluded from thrombolysis as well as the most severe thrombolysis-eligible to centers able to perform primary PTCA round the clock, which exist in nearly every large urban center. When the patient is thrombolysis-eligible and is within a center in which interventional facilities and experienced teams are immediately available, both treatments are legitimate, although primary PTCA may be favored both in terms of outcome and cost. Conversely, when the patient has no contraindication to thrombolysis and cannot be treated rapidly in a center with interventional capabilities, thrombolytic therapy should remain the preferred treatment.
7 schema:genre article
8 schema:inLanguage en
9 schema:isAccessibleForFree false
10 schema:isPartOf N15e41ae1a493459db639ee3916fc80fc
11 N9f0ed9c475b54c23b6a502a41c66ba11
12 sg:journal.1113719
13 schema:keywords ECG criteria
14 PTCA
15 acute myocardial infarction
16 acute myocardial infarction patients
17 availability
18 capability
19 cardiology facilities
20 care center
21 center
22 choice
23 clock
24 contraindications
25 cost
26 cost-effective treatment
27 criteria
28 discharge
29 early hospital discharge
30 experienced team
31 facilities
32 hospital discharge
33 increase
34 infarction
35 infarction patients
36 interventional capabilities
37 interventional cardiology facilities
38 interventional facilities
39 intravenous thrombolysis
40 ischemia
41 large urban centers
42 logistical problems
43 management
44 medical system
45 myocardial infarction
46 myocardial infarction patients
47 need
48 ongoing acute myocardial infarction
49 only choice
50 only possible reperfusion therapy
51 outcomes
52 patients
53 permanent availability
54 possible reperfusion therapy
55 pre-hospital medical systems
56 preferred treatment
57 primary PTCA
58 primary care centers
59 problem
60 proportion
61 readmission
62 recurrent ischemia
63 reduced readmissions
64 reduced risk
65 reperfusion
66 reperfusion therapy
67 risk
68 secondary transfer
69 staff
70 substantial increase
71 system
72 team
73 terms
74 terms of outcomes
75 therapy
76 thrombolysis
77 thrombolytic therapy
78 transfer
79 treatment
80 urban centers
81 use
82 schema:name Primary PTCA: Possibly the Best, Often the Only Choice for Reperfusion in Acute Myocardial Infarction
83 schema:pagination 331-336
84 schema:productId N49171f4d9e0145bda258da485312674c
85 N788cff6c5da742459ecc3388258ac6f3
86 N8f09b549bdf14900bf7ad89049bbec00
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026647935
88 https://doi.org/10.1023/a:1008837014116
89 schema:sdDatePublished 2022-01-01T18:09
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N63c41f07ff90479aa92990965c368f5a
92 schema:url https://doi.org/10.1023/a:1008837014116
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N15e41ae1a493459db639ee3916fc80fc schema:volumeNumber 4
97 rdf:type schema:PublicationVolume
98 N2a4f07ea5f714aa3808fd3e3e8ee8e20 rdf:first sg:person.01221261443.91
99 rdf:rest rdf:nil
100 N49171f4d9e0145bda258da485312674c schema:name doi
101 schema:value 10.1023/a:1008837014116
102 rdf:type schema:PropertyValue
103 N63c41f07ff90479aa92990965c368f5a schema:name Springer Nature - SN SciGraph project
104 rdf:type schema:Organization
105 N788cff6c5da742459ecc3388258ac6f3 schema:name dimensions_id
106 schema:value pub.1026647935
107 rdf:type schema:PropertyValue
108 N8f09b549bdf14900bf7ad89049bbec00 schema:name pubmed_id
109 schema:value 10639637
110 rdf:type schema:PropertyValue
111 N9f0ed9c475b54c23b6a502a41c66ba11 schema:issueNumber 3-4
112 rdf:type schema:PublicationIssue
113 Nf1b36b86837f401199ab31fb7ea60210 rdf:first sg:person.01300751563.11
114 rdf:rest N2a4f07ea5f714aa3808fd3e3e8ee8e20
115 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
116 schema:name Medical and Health Sciences
117 rdf:type schema:DefinedTerm
118 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
119 schema:name Clinical Sciences
120 rdf:type schema:DefinedTerm
121 sg:journal.1113719 schema:issn 0929-5305
122 1573-742X
123 schema:name Journal of Thrombosis and Thrombolysis
124 schema:publisher Springer Nature
125 rdf:type schema:Periodical
126 sg:person.01221261443.91 schema:affiliation grid-institutes:grid.411119.d
127 schema:familyName Seknadji
128 schema:givenName Patrick
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221261443.91
130 rdf:type schema:Person
131 sg:person.01300751563.11 schema:affiliation grid-institutes:grid.411119.d
132 schema:familyName Steg
133 schema:givenName Gabriel
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300751563.11
135 rdf:type schema:Person
136 grid-institutes:grid.411119.d schema:alternateName Cardiology Department, Höpital Bichat, Paris, France
137 schema:name Cardiology Department, Höpital Bichat, Paris, France
138 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...